IRVINE, Calif., October 29, 2018 — Ascendiant Capital Markets, LLC (“Ascendiant”) announced today the initiation of research coverage on Hemispherx Biopharma, Inc. (NYSE American: HEB) of Ocala, Florida. For a copy of the initiation report, please click here.